2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
Abstract
This invention presents methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented by the compounds include rheumatoid arthritis and / or its associated symptoms, systemic lupus erythematosus and / or its associated symptoms and multiple sclerosis and its associated symptoms.
Term
No projected expiry on record.
- Priority
- Filed and published
- Today
1 claim: 1 independent, 0 dependent
- 1R® R®
1 paragraph, as filed
This invention presents methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented by the compounds include rheumatoid arthritis and / or its associated symptoms, systemic lupus erythematosus and / or its associated symptoms and multiple sclerosis and its associated symptoms.
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| NO339146B1 | Cited by | Norway | Search report |
155 members in 31 offices
Priority claims16
| Document | Office | Kind | Date |
|---|---|---|---|
| 49164103 | United States of America | P | |
| 49164103 | United States of America | P | |
| 53159803 | United States of America | P | |
| 53159803 | United States of America | P | |
| 57224604 | United States of America | P | |
| 57224604 | United States of America | P | |
| 2004024716 | United States of America | W | |
| 2004024716 | United States of America | W | |
| 60491641 | – | – | – |
| 60531598 | – | – | – |
| 60572246 | – | – | – |
| PCTUS0424716 | – | – | – |
| US20030491641P | – | – | – |
| US20030531598P | – | – | – |
| US20040572246P | – | – | – |
| WO2004US24716 | – | – | – |
Members155
| Document | Office | Kind | |
|---|---|---|---|
| WO2005012294A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2005013996A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2004265288A1 | Australia | A1 | |
| CA2533377A1 | Canada | A1 | |
| WO2005016893A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2005113398A1 | United States of America | A1 | |
| WO2005013996A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2005016893A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2005063722A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2005192301A1 | United States of America | A1 | |
| US2005209224A1 | United States of America | A1 | |
| US2005234049A1 | United States of America | A1 | |
| CA2566531A1 | Canada | A1 | |
| WO2005118544A2 | World Intellectual Property Organization (WIPO) | A2 | |
| GB0523012D0 | United Kingdom | D0 | |
| WO2005012294A8 | World Intellectual Property Organization (WIPO) | A8 | |
| US2006035891A1 | United States of America | A1 | |
| WO2005118544A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO20060992LThis record | Norway | L | |
| ITMI20052171A1 | Italy | A1 | |
| EP1656372A2 | European Patent Office (EPO) | A2 | |
| FR2877944A1 | France | A1 | |
| KR20060056353A | Republic of Korea | A | |
| AU2005307849A1 | Australia | A1 | |
| CA2580150A1 | Canada | A1 | |
| WO2006055561A2 | World Intellectual Property Organization (WIPO) | A2 | |
| GB2420559A | United Kingdom | A | |
| EP1663242A2 | European Patent Office (EPO) | A2 | |
| IL173299D0 | Israel | D0 | |
| DE102005054092A1 | Germany | A1 | |
| US2006167249A1 | United States of America | A1 | |
| EP1694652A1 | European Patent Office (EPO) | A1 | |
| BRPI0413018A | Brazil | A | |
| US7122542B2 | United States of America | B2 | |
| CN1849318A | China | A | |
| HK1091209A1 | Hong Kong, China | A1 | |
| JP2007500722A | Japan | A | |
| JP2007501793A | Japan | A | |
| EP1763514A2 | European Patent Office (EPO) | A2 | |
| JP2007514775A | Japan | A | |
| NO20073068L | Norway | L | |
| IL181923D0 | Israel | D0 | |
| US2007167439A1 | United States of America | A1 | |
| US2007179140A1 | United States of America | A1 | |
| KR20070085571A | Republic of Korea | A | |
| EP1824489A2 | European Patent Office (EPO) | A2 | |
| RU2006106180A | Russian Federation | A | |
| US2007225495A1 | United States of America | A1 | |
| MX2007005807A | Mexico | A | |
| JP2007538092A | Japan | A | |
| US2007299060A1 | United States of America | A1 | |
| US2008009484A1 | United States of America | A1 | |
| US2008009494A1 | United States of America | A1 | |
| US2008021020A1 | United States of America | A1 | |
| US2008027045A1 | United States of America | A1 | |
| US2008051412A1 | United States of America | A1 | |
| ES2296477A1 | Spain | A1 | |
| CN101171012A | China | A | |
| ZA200601460B | South Africa | B | |
| WO2006055561A3 | World Intellectual Property Organization (WIPO) | A3 | |
| RS20060073A | Serbia | A | |
| JP2008520580A | Japan | A | |
| GB2420559B | United Kingdom | B | |
| BRPI0516795A | Brazil | A | |
| ZA200702180B | South Africa | B | |
| SG145698A1 | Singapore | A1 | |
| HK1114338A1 | Hong Kong, China | A1 | |
| US7452879B2 | United States of America | B2 | |
| US2008312438A1 | United States of America | A1 | |
| RU2007122381A | Russian Federation | A | |
| US7511137B2 | United States of America | B2 | |
| RU2356901C2 | Russian Federation | C2 | |
| US2009137589A1 | United States of America | A1 | |
| US2009176981A1 | United States of America | A1 | |
| US7560466B2 | United States of America | B2 | |
| US7582648B2 | United States of America | B2 | |
| UA88660C2 | Ukraine | C2 | |
| US2009318687A1 | United States of America | A1 | |
| NZ545270A | New Zealand | A | |
| UA91000C2 | Ukraine | C2 | |
| US7754714B2 | United States of America | B2 | |
| NZ554419A | New Zealand | A | |
| US7858633B2 | United States of America | B2 | |
| US7863286B2 | United States of America | B2 | |
| EP1824489B1 | European Patent Office (EPO) | B1 | |
| US7868013B2 | United States of America | B2 | |
| AT494280T | Austria | T | |
| ATE494280T1 | Austria | T1 | |
| US7884111B2 | United States of America | B2 | |
| AU2011200367A1 | Australia | A1 | |
| DE602005025803D1 | Germany | D1 | |
| RU2416604C2 | Russian Federation | C2 | |
| DK1824489T3 | Denmark | T3 | |
| EP1663242B1 | European Patent Office (EPO) | B1 | |
| AT506953T | Austria | T | |
| ATE506953T1 | Austria | T1 | |
| ES2359416T3 | Spain | T3 | |
| SI1824489T1 | Slovenia | T1 | |
| DE602004032446D1 | Germany | D1 | |
| US2011152518A1 | United States of America | A1 |
Numbers
- Publication, DOCDB
- 20060992
- Publication, EPODOC
- NO20060992L
- Application
- 992
- Application, DOCDB
- 20060992
- Application, EPODOC
- NO20060000992
Titles2
- Norwegian
- Metoder for behandling eller forebygging av autiommune sykdommer med 2,4-pyrimidindiaminforbindelser
- English
- Methods of Treatment or Prevention of Autonomic Diseases with 2,4-pyrimidinediamine Compounds
Classification
- CPC, 15
- C07D413/14
- C07D498/04
- C07D403/12
- C07D405/12
- C07D405/14
- C07D413/12
- C07D417/12
- C07D417/14
- C07D498/06
- A61K31/506
- A61K31/541
- C07D403/14
- C07D498/02
- A61K31/538
- A61P19/02
- IPC, 18
- C07D403 12
- A61K31 505
- A61K31 506
- A61K31 538
- A61K31 5415
- A61K31 542
- A61P37 00
- C07D405 12
- C07D405 14
- C07D413 02
- C07D413 12
- C07D413 14
- C07D417 02
- C07D417 12
- C07D417 14
- C07D498 02
- C07D498 04
- C07D498 06